When does FunPep (4881.T) report earnings?

FunPep (4881.T) schedules its earnings announcement on **12 Feb 2026** in the pre-market session. Investors should watch clinical updates and cash guidance within that release for immediate market impact.

What is Meyka AI's 12-month forecast for 4881.T stock?

Meyka AI's forecast model projects a **12-month target of JPY 43.65** for 4881.T stock. Compared with the current **JPY 105.00**, this implies a **-58.43%** downside. Forecasts are model projections and not guarantees.

What are the main risks for 4881.T stock?

Primary risks include clinical trial setbacks, cash burn and potential dilution. Financial metrics show negative EPS (**-42.10**) and low revenue per share, increasing sensitivity to trial news and financing.

How liquid is 4881.T stock ahead of earnings?

Pre-market volume is elevated at **10,363,800.00** shares versus an average of **791,378.00**, giving a relative volume of **5.16**. High relative volume can magnify price swings in the thin biotech float.

JP Stocks

Pre-market: 4881.T FunPep (JPX) JPY 105 ahead of 12 Feb 2026 earnings : watch model downside

ByDanny Kontos February 12, 2026February 12, 2026

FunPep Company Limited (4881.T) opens pre-market on 12 Feb 2026 at JPY 105.00 ahead of a scheduled earnings announcement later today. Investors will focus on clinical progress and cash runway, given the company’s biotech pipeline and negative earnings history. Early session volume is already elevated at 10,363,800.00 shares versus an average of 791,378.00, signalling heavy positioning. We examine earnings drivers, valuation, technicals and Meyka AI forecasts to frame likely price reaction to the report.